Régis Peffault de Latour
About
Régis Peffault de Latour is a scholar working on Hematology, Immunology and Genetics.
According to data from OpenAlex, Régis Peffault de Latour has authored 384 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 248 papers in Hematology, 169 papers in Immunology and 88 papers in Genetics. Recurrent topics in Régis Peffault de Latour's work include Hematopoietic Stem Cell Transplantation (168 papers), Complement system in diseases (98 papers) and Acute Myeloid Leukemia Research (62 papers). Régis Peffault de Latour is often cited by papers focused on Hematopoietic Stem Cell Transplantation (168 papers), Complement system in diseases (98 papers) and Acute Myeloid Leukemia Research (62 papers). Régis Peffault de Latour collaborates with scholars based in France, United States and Italy. Régis Peffault de Latour's co-authors include Gèrard Socié, Marie Robin, Patricia Ribaud, Aliénor Xhaard, Antonio M. Risitano, Raphaël Porcher, Mohamad Mohty, Flore Sicre de Fontbrune, Vanderson Rocha and Éliane Gluckman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.
In The Last Decade
Régis Peffault de Latour
361 papers receiving 8.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Régis Peffault de Latour France | 51 | 4.5k | 3.7k | 1.8k | 1.5k | 1.2k | 384 | 8.6k | ||
| Judith Marsh United Kingdom | 52 | 6.6k 1.5× | 2.7k 0.7× | 1.8k 1.0× | 2.0k 1.3× | 490 0.4× | 210 | 9.1k | ||
| Ryotaro Nakamura United States | 41 | 3.0k 0.7× | 2.3k 0.6× | 949 0.5× | 1.0k 0.7× | 1.0k 0.9× | 219 | 5.6k | ||
| Phillip Scheinberg United States | 41 | 4.3k 1.0× | 2.5k 0.7× | 1.3k 0.7× | 1.1k 0.7× | 774 0.7× | 153 | 7.1k | ||
| Lionel Galicier France | 47 | 3.5k 0.8× | 3.8k 1.0× | 1.8k 1.0× | 962 0.6× | 947 0.8× | 184 | 7.8k | ||
| Anneke Brand Netherlands | 55 | 5.4k 1.2× | 2.3k 0.6× | 988 0.6× | 1.4k 0.9× | 925 0.8× | 291 | 11.0k | ||
| Carlomaurizio Montecucco Italy | 54 | 1.9k 0.4× | 2.3k 0.6× | 799 0.4× | 1.0k 0.7× | 950 0.8× | 436 | 9.9k | ||
| Paul Coppo France | 42 | 4.0k 0.9× | 5.6k 1.5× | 791 0.4× | 1.8k 1.2× | 523 0.4× | 248 | 7.9k | ||
| Vincent T. Ho United States | 65 | 10.4k 2.3× | 5.8k 1.6× | 3.4k 1.9× | 2.1k 1.4× | 1.2k 1.0× | 323 | 14.9k | ||
| Masja de Haas Netherlands | 56 | 4.9k 1.1× | 3.2k 0.9× | 764 0.4× | 1.4k 0.9× | 717 0.6× | 275 | 9.8k | ||
| Alberto Bosi Italy | 57 | 6.1k 1.4× | 1.8k 0.5× | 2.3k 1.3× | 3.6k 2.3× | 991 0.8× | 321 | 10.5k |
Countries citing papers authored by Régis Peffault de Latour
Since
Specialization
Citations
This map shows the geographic impact of Régis Peffault de Latour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Régis Peffault de Latour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Régis Peffault de Latour more than expected).
Fields of papers citing papers by Régis Peffault de Latour
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Régis Peffault de Latour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Régis Peffault de Latour. The network helps show where Régis Peffault de Latour may publish in the future.
Co-authorship network of co-authors of Régis Peffault de Latour
This figure shows the co-authorship network connecting the top 25 collaborators of Régis Peffault de Latour. A scholar is included among the top collaborators of Régis Peffault de Latour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Régis Peffault de Latour. Régis Peffault de Latour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Beddok, Arnaud, Eunike Velleuer, Ruud H. Brakenhoff, et al.. (2025). Strategies for early detection and detailed characterization of oral lesions and head and neck squamous cell carcinoma in Fanconi anemia patients. Cancer Letters. 617. 217529–217529.
2.
Wynn, Robert, Fernanda Volt, Philippe Guardiola, et al.. (2025). Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantation. Blood Advances. 9(17). 4425–4435.
3.
Kulasekararaj, Austin, Robert A. Brodsky, Hubert Schrezenmeier, et al.. (2025). Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria. Annals of Hematology. 104(1). 81–94.
4.
Nishimori, Hisakazu, Shinobu Tamura, Toshiki Uchida, et al.. (2024). Efficacy, Safety, and Quality of Life of Pegcetacoplan in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria Treated within the Phase 3 PEGASUS Trial. Acta Haematologica. 148(1). 1–14.
5.
Penack, Olaf, Christophe Peczynski, Nicolaus Kröger, et al.. (2024). ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?. Leukemia. 38(5). 1156–1163.
6.
Xhaard, Aliénor, Marie Robin, Flore Sicre de Fontbrune, et al.. (2024). Donor/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigens. Bone Marrow Transplantation. 59(9). 1232–1238.
7.
Yakoub‐Agha, Ibrahim, Raffaella Greco, Francesco Onida, et al.. (2023). Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone Marrow Transplantation. 58(6). 696–700.
8.
Risitano, Antonio M., David J. Araten, David J. Kuter, et al.. (2023). PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL. HemaSphere. 7(S3). e08587b7–e08587b7.
9.
Latour, Régis Peffault de, Jeff Szer, Austin Kulasekararaj, et al.. (2023). PB2064: THE COMPLETE STUDY: A SINGLE ARM, MULTICENTER OBSERVATIONAL STUDY TO EVALUATE EFFECTIVENESS OF PEGCETACOPLAN UNDER REAL WORLD CONDITIONS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH). HemaSphere. 7(S3). e36410cc–e36410cc.
10.
Passweg, Jakob, Helen Baldomero, Christian Chabannon, et al.. (2022). Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey. Bone Marrow Transplantation. 57(5). 742–752.
11.
Morin, Florence, Corinne Pondarré, Régis Peffault de Latour, et al.. (2021). Early Immune Reconstitution after Hematopoietic Stem Cell Transplantation for Adolescents and Adults with Sickle Cell Disease. Blood. 138(Supplement 1). 3907–3907.
12.
Chabannon, Christian, Régis Peffault de Latour, Bénédicte Neven, et al.. (2021). CAR-T cells : comment le registre de l’EBMT monitore les activités en Europe, identifie les contraintes et prépare l’évolution des régulations. Bulletin du Cancer. 108(10). S155–S161.
13.
Ljungman, Per, Małgorzata Mikulska, Rafael de la Cámara, et al.. (2020). Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplantation. 56(3). 755–755.
14.
Miller, P.D., John A. Snowden, Régis Peffault de Latour, et al.. (2019). Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 55(2). 441–451.
15.
Pagliuca, Simona, David Michonneau, Véronique Meignin, et al.. (2019). Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(12). 2490–2500.
16.
Bédossa, Pierre, Pierre‐Emmanuel Rautou, Philippe Bertheau, et al.. (2018). Utility and Safety of Liver Biopsy in Patients with Undetermined Liver Blood Test Anomalies after Allogeneic Hematopoietic Stem Cell Transplantation: A Monocentric Retrospective Cohort Study. Biology of Blood and Marrow Transplantation. 24(12). 2523–2531.
17.
Hurabielle, Charlotte, Maxime Battistella, C. Ram‐Wolff, et al.. (2018). Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016. Annales de Dermatologie et de Vénéréologie. 145(6-7). 405–412.
18.
Bergeron, Anne, Sylvie Chevret, Karine Chagnon, et al.. (2015). Budesonide/Formoterol for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation. American Journal of Respiratory and Critical Care Medicine. 191(11). 1242–1249.
19.
Latour, Régis Peffault de, Véronique Frémeaux‐Bacchi, Raphaël Porcher, et al.. (2014). Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab. Blood. 125(5). 775–783.
20.
Gouill, Steven Le, Nöel Milpied, Agnès Buzyn, et al.. (2008). Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire. Journal of Clinical Oncology. 26(14). 2264–2271.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Judith Marsh Breakdown of academic impact, for papers by Ryotaro Nakamura Breakdown of academic impact, for papers by Phillip Scheinberg Breakdown of academic impact, for papers by Lionel Galicier Breakdown of academic impact, for papers by Anneke Brand Breakdown of academic impact, for papers by Carlomaurizio Montecucco Breakdown of academic impact, for papers by Paul Coppo Breakdown of academic impact, for papers by Vincent T. Ho Breakdown of academic impact, for papers by Masja de Haas Breakdown of academic impact, for papers by Alberto Bosi